Hi, what are you looking for?
– The price is high because Teva considers Cipla an ideal fit. – Please help us out : Will you offer us a hand?...
– The Phase III trial results showed significant improvement in the treatment of chronic low back pain. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– “Bloomberg” says investors are wondering how long Teva can stay out of the game. “Drugmakers on an acquisition spree have created...
– Teva CSO Dr. Michael Hayden: We are disappointed with these results. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) today announced...
– Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan. – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company...
– The US Supreme Court has in effect allowed generic versions of the MS drug from next month. – – Teva Pharmaceutical Industries Ltd. TEVATEVA (NYSE: ;...
– Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its...
– Teva is resuming investments in Israeli startups. Sources inform ”Globes” that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Philips Healthcare jointly bid in the Office...
– – The US Supreme Court has agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) over the expiry of its patents for...
– A federal judge in Virginia ruled that the patent for Pfizer’s Celebrex expires in May. – A US federal judge in Virginia has...